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ABSTRACT
Summary: We present MutaGeneSys: a system that uses genome-
wide genotype data for disease prediction. Our system integrates
three data sources: the International HapMap project, whole-genome
marker correlation data and the Online Mendelian Inheritance in Man
(OMIM) database. It accepts SNP data of individuals as query input
and delivers disease susceptibility hypotheses even if the original set
of typed SNPs is incomplete. Our system is scalable and flexible: it
operates in real time and can be configured on the fly to produce
population, technology, and confidence-specific predictions.
Availability: Efforts are underway to deploy our system as part of the




Availability of genetic information continues to revolutionize the
way we look at medicine, with an ever stronger trend towards perso-
nalized diagnostics and treatment of heritable conditions. One pro-
mising research direction considers the evaluation of an individual’s
susceptibility to disease based on single nucleotide polymorphisms
(SNPs)  DNA sequence variations occurring when a single nucleo-
tide in the genome differs between members of the species. Signi-
cant attention of the research community is devoted to determining
direct causal association between the genotype and the phenotype,
and many interesting correlations have already been reported. The
Online Mendelian Inheritance in Man (OMIM)[6] database is the
currently most complete source of associations between high-prole
phenotypes and genotypes. A text search of OMIM yields, for exam-
ple, a correlation between a C-T SNP (rs908832) in exon 14 of
the ABCA2 gene and Alzheimer disease, an association of two
C-reactive protein (CRP) polymorphisms, rs1800947 and rs1205,
with Systemic Lupus Erythematosus and antinuclear antibody pro-
duction, and a connection between an nsSNP in the IFIH1 gene,
rs1990760, and insulin-dependent Diabetes Mellitus.
Fully exploiting genetic information for disease prediction is
difcult for two reasons. First and foremost, genetic information
remains expensive to collect, and it is currently economically prohi-
bitive to make a complete set of an individual’s genotypes of SNPs
available for analysis. Nature Genetics’ Question of the Year[5]
announced the sequencing of the entire human genome for $1,000
as a goal for the genetics community. Cost effective methods (e.g.
SNP arrays) currently exist for collecting genetic data from 1-5%
if all 11 million human SNPs. This calls for the development of
techniques that can effectively utilize partial genetic information for
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disease prediction. The second reason is that OMIM is accessible
only in text form, and while there is some amount of cross-reference
between OMIM and other NCBI databases, using this data for
automated genome-wide diagnostics remains difcult.
Several studies, culminating with the International HapMap
project[7], report on a signicant amount of correlation among
markers in the genome[9]. This genomic redundancy enables one
to start with an incomplete set of typed SNPs, and expand this
set by including associated proxies. Indirect association between
proxy genotype and phenotype is precisely the tool that is needed
for effective and efcient association analysis.
In the simplest case, SNPs are correlated pairwise, and one of
them may be predicted by the other; such correlations are referred
to as single-marker predictors. Many two-marker and three-marker
predictors are also known. Correlations between causal SNPs and
their proxies are associated with a coefcient of determination
(squared Pearson’s correlation coefcient) r2[0, 1]. Marker corre-
lation is population-dependent[8]; the coefcient of determination
may also depend on the genotyping technology and the resolution
that were used to compile the marker correlation data. For example,
according to our marker correlation dataset[2], rs12076827 (allele
A) and rs1572970 (allele A) on chromosome 1 together determine
that rs1205 will appear with minor allele T, with r2 = 0.733 (in
the Japanese and Chinese population). This correlation was establis-
hed using the Affymetrix GeneChip genotyping technology at 500K
resolution. OMIM links rs1205 with Systemic Lupus Erythematosus
(SLE) and antinuclear antibody production.
Genome-wide correlation can be used to augment an indivi-
dual’s genetic information, greatly enhancing its diagnostic value.
In the example above, if rs1205 was not typed, but rs12076827
and rs1572970 were, an association with the SLE-causing phe-
notype could still be determined. Our project is the rst step in
this direction. The goal of our project is to stream-line the pro-
cess of correlating SNP information with heritable disorders, and
to enable real-time retrieval of disease susceptibility hypotheses on
genome-wide scale. The aims of our system are two-fold.
• To create a exible, extensible, and efcient framework for
storage and querying of direct and indirect association data.
• To provide a set of tools for data import and maintenance,
and to use these tools to populate the database with currently
available direct and indirect association data.
We use and integrate three datasets: the International HapMap
project [7], Online Mendelian Inheritance in Man [6]  an on-line
repository of articles about human genes and genetic disorders, and
a dataset of marker correlations [2].
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Our effort only partially overlaps systems such as the Genetic
Association Database (GAD)[3] and the database of Genotype and
Phenotype (dbGaP)[1]. GAD correlates different kinds of genetic
data across a variety of data sources, including also the OMIM data-
base. To the best of our knowledge, GAD has no facilities to use
individual genotype data as part of a query. dbGaP focuses on archi-
ving and distribution of results of studies that have investigated the
interaction of genotype and phenotype. The system provides brow-
sing and navigation facilities that can be customized on a per-study
basis, by dening study-specic variables. dbGaP does not provide
automatic integration of genome-wide marker correlation data with
study results, and could be enhanced by integrating a system such
as ours.
Our system is scalable and exible: it operates in real time and
can be congured on the y to produce population, technology, and
condence-specic predictions. Efforts are underway to deploy our
system as part of the NCBI Reference Assembly.
We discuss the design of our system in Section 2, describe some




To address the rst aim of our project, we designed a relational data-
base schema for storage and querying of genotype and association
data. We chose to use Oracle 10g, a commercial relational database
system, in our implementation. A different relational platform may
also be used to host a system such as ours; our decision to use Oracle
is based primarily on query performance, and on availability of an
XML package that we use for query result formatting.
The database schema is divided into three areas.
Allele frequency and marker correlation data
This is the most important area of the data repository, populated
using the techniques described in Section 2.2. HapMap, marker cor-
relation, and OMIM data is parsed and loaded into database tables
for permanent storage. We then create a materialized view (a mate-
rialized logical table) that contains a transitive closure of direct and
indirect associations between SNPs on whole genome array and
OMIM records. Each row of this view includes information about
population, technology, resolution, coefcient of determination, and
the assumed source and target alleles. As new correlation data beco-
mes available, it is loaded into permanent storage. The materialized
view can then be re-built on demand; and takes less than 5 minu-
tes on currently available data: the entire HapMap genome, marker
correlation, and OMIM data.
Genotype and other data pertaining to an individual
If a user wishes to run association study wide or individual-
specic diagnostic genotype queries, he must populate these tables.
We provide command-line utilities for loading data in HapMap[7],
IntraGenDB[4] and standard linkage formats.
Request and result tables
To initiate an association and diagnostic request, the user inserts
an entry into the request table, specifying request parameters.
Currently supported parameters are: population, technology, reso-
lution, and coefcient of determination. Upon completion of the
request, the system populates the result table with discovered SNP-
disorder associations. Results may be displayed in XML format, or
retrieved directly from the result table.
2.2 Data Processing and Integration
The HapMap dataset is a comprehensive repository of SNP geno-
types. We use this dataset to compile population-specic lists of
alleles and allele frequencies for the known SNPs. Our prediction
dataset consists of single- and two-marker correlations; conse-
quently, these are the types of correlation that our system supports.
We provide a command-line utility for loading correlation data.
Additional strategies for marker prediction may be accommodated
by implementing similar load utilities.
Both HapMap and our marker correlation dataset are clean and
non-redundant, available in comma-separated format, and lend
themselves well to straight-forward processing. The challenge with
these two datasets is the sheer volume of data and, consequently,
the size of the full transitive closure of marker correlations. It turns
out that while there is a lot of information regarding correlations
along the genome (the marker correlation dataset is large), relatively
little is still known about correlations between SNPs and herita-
ble disorders. We observe that our system can take advantage of
marker correlations only if they ultimately lead to a hypothesis of
disease susceptibility, and use available marker-to-disorder data as
the limiting factor. In other words, an correlation between SNP1
and SNP2 is only useful if at least one of these SNPs is associated
with a heritable disorder.
We currently use OMIM, a repository of publications about
human genes and genetic disorders, as our data source for marker
to disorder associations. Associations between SNPs and diseases
are not readily available and we resort to parsing this information
from the text. We use a very simple method for this extraction: we
process OMIM record by record, looking for occurrences of rs num-
bers (cross-references from OMIM to dbSNP), in the text of the
article. We then assume that the mentioned SNP is associated with
the heritable trait to which the current OMIM record pertains.
We made an assumption when associating SNPs with OMIM
records: for lack of information, when OMIM mentions that an SNP
is associated with a disorder, we assume that it refers to the minor
allele.
There is nothing to prevent one from using more sophisticated
Natural Language Processing techniques, or work with a different
dataset that has genotype to phenotype associations readily available
in machine-readable form. We provide parsing and data load utili-
ties for OMIM. Similar utilities may be implemented for alternative
datasets.
3 RESULTS
As mentioned earlier, our database contains a signicant amount
of SNP and marker correlation data, but only a limited number of
SNP to OMIM associations. Across all populations and platforms
we store over 10 million SNP records, close to 50 million single
correlation records, and over 20 million double correlation records.
However, out of 18000 articles in the OMIM repository, only 187
mention associations between heritable disorders and SNPs, with
133 unique participating SNPs. Combining OMIM with marker
correlation data, we are able to make diagnostic predictions for addi-
tional 328 unique single-marker pairs, and 396 double-marker sets.
The dataset is enriched with a total of 1312 population-specic cor-
relations. The number of diagnostic predictions will grow as more
information about direct associations between SNPs and heritable
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disorders becomes available, i.e. when OMIM is extended, or a new
data source becomes available.
For an example of the effectiveness of MutaGeneSys, consider
age related macular degeneration (ARMD). According to OMIM,
two SNPs are implicated in this disorder: rs3793784 in the ERCC6
gene and rs380390 in the CFH gene. MutaGeneSys contains 72
additional SNPs that are associated with the ARMD. As ano-
ther example, Systemic Lupus Erythematosus (SLE) is associated
with two CRP polymorphisms in OMIM; MutaGeneSys uses 15
additional unique SNPs to diagnose SLE.
MutaGeneSys is installed on a Pentium 4 with a 3GHz CPU and
only 512MB of RAM, running Red Hat Enterprise Linux 4 and
Oracle 10g Enterprise Edition. We tested the performance of our
system on IntraGenDB[4] data, and found that diagnostic associa-
tion requests run in interactive time: in under 5 seconds for full
genotype scans of approximately 317,000 SNPs per DNA sample.
This time does not include loading the genetic information into the
database, which took an additional 60-90 seconds. Running our
system on a faster machine with more RAM will likely further
improve its performance.
4 CONCLUSION
We presented MutaGeneSys: a scalable system that uses genome-
wide genotype data for disease prediction. MutaGeneSys allows
detection of individuals susceptible to OMIM disorders among par-
ticipants of whole genome association studies, a yet unexplored
perspective of such data. In the longer run, we believe this system
and its successors will pave the way for using whole genome SNP
arrays as practical diagnostic tools, advancing them from bench to
bedside.
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